Financials Quoin Pharmaceuticals, Ltd.

Equities

Delayed Nasdaq Other stock markets 16:22:10 09/12/2025 GMT			5-day change	1st Jan Change
14.00 ^USD	-6.98%		-26.97%	-38.53%

12-05	Top Premarket Decliners	MT
11-11	Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	-	-	-	-	-	-	-	37.47
Change	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EBIT ¹	-	-6.063	-9.258	-9.378	-9.528	-15.8	-20.79	8.426
Change	-	-	-52.7%	-1.3%	-1.6%	-65.83%	-31.56%	140.54%
Interest Paid	-	-1.09	-0.7141	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-21.46	-9.382	-8.687	-8.962	-15.63	-17.9	-1.351
Change	-	-	56.29%	7.41%	-3.18%	-74.38%	-14.53%	92.45%
Net income ¹	-2.095	-21.46	-9.447	-8.687	-8.962	-15.44	-17.9	-1.351
Change	-	-924.29%	55.98%	8.05%	-3.18%	-72.24%	-15.96%	92.45%
Announcement Date	16/06/21	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-1.303	-2.981	-2.176	-2.668	-2.328	-2.086	-2.776	-2.26	-2.125	-2.218	-	-2.137	-2.528	-2.405	-3.957	-3.793	-4.02	-4.031
Change	-	-128.85%	27.01%	-22.62%	12.77%	10.38%	-33.06%	18.57%	5.97%	-4.35%	-	-	-18.29%	4.86%	-64.54%	4.14%	-5.98%	-0.27%
Charge d'intérêts	-0.2482	-0.5741	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-11.82	-1.683	-2.668	-3.03	-2.001	-2.603	-2.107	-1.927	-2.05	-	-1.974	-2.35	-2.311	-3.812	-	-3.948	-4.173
Change	-	-	85.76%	-58.56%	-13.54%	33.95%	-30.09%	19.06%	8.56%	-6.39%	-	-	-19.04%	1.64%	-64.94%	-	-	-5.69%
Net income ¹	-1.404	-11.82	-1.683	-2.668	-3.095	-2.001	-2.603	-2.107	-1.927	-2.05	-	-1.974	-2.35	-2.311	-3.812	-3.696	-3.948	-3.981
Change	-	-741.59%	85.76%	-58.56%	-15.99%	35.35%	-30.09%	19.06%	8.56%	-6.39%	-	-	-19.04%	1.64%	-64.94%	3.05%	-6.82%	-0.82%
Announcement Date	20/12/21	14/04/22	23/05/22	18/08/22	10/11/22	09/03/23	09/05/23	03/08/23	09/11/23	13/03/24	09/05/24	08/08/24	08/11/24	13/03/25	13/05/25	07/08/25	06/11/25	-

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	16/06/21	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-

Estimates

Fiscal Period: December	2021	2022	2023	2024
CAPEX ¹	-	-	-	-
Change	-	-	-	-
Free Cash Flow (FCF) ¹	-3.583	-6.214	-4.684	-4.275
Change	-	-73.41%	24.62%	8.73%
Announcement Date	14/04/22	15/03/23	14/03/24	13/03/25

¹USD in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-	-	22.49%
EBT Margin (%)	-	-	-	-	-	-	-	-	-3.61%
Net margin (%)	-	-	-	-	-	-	-	-	-3.61%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	21.57%	-	-	-	-	-	-
Profitability
ROA	-	-87.18%	-70.6%	-48.59%	-44.03%	-42.72%	-	-	-
ROE	-	37.69%	721.4%	-232.68%	-132.92%	-120.55%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-0.57x	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-11,025	-28,455	-1,638	-337.4	-66.85	-20.16	-6.91	-0.52
Change	-	-	-158.1%	94.24%	79.4%	80.19%	69.85%	65.72%	92.47%
Nbr of stocks (in thousands)	-	-	1.59	11.5	28.2	234	839	839	839
Announcement Date	-	16/06/21	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-